35 Years on TRT + Steroids with Perfect Labs at 60 – How I Did It (& You Can Too)

A sixty year old man describes more than thirty five years using testosterone and intermittent anabolic steroids. The core claim is that long term use can look very different when risk factors are controlled aggressively. An internal medicine perspective is used to explain why the ABCDS framework stays central for longevity. Early life training goals are described as shifting toward health preservation as age increases steadily. A concept of competing forces is introduced, describing adverse vectors that push organs toward damage. Protective vectors are described as habits and medical strategies that counter those adverse forces. The overall message stresses that decades of exposure demand constant humility and monitoring.

Blood pressure is emphasized repeatedly as the first lever to control for long term safety. Hypertension is described as silently injuring the heart, kidneys, and vascular endothelium over years. Home measurements and clinician follow up are presented as practical steps for early detection. Cholesterol management is discussed as a parallel priority because atherosclerosis progresses quietly. Statin therapy is referenced as a tool, yet the focus stays on targeted dosing and individualized thresholds. Coronary artery disease is discussed as preventable for many people who manage lipids and blood pressure early. Lifestyle structure is described as supporting these goals through sleep, training, and consistent nutrition.

Red blood cell elevation is discussed as a predictable effect when androgens push erythropoietic signaling. Hemoglobin, hematocrit, and polycythemia risk are framed as laboratory problems that require deliberate planning. Sleep apnea is described as a common amplifier that worsens oxygen stress and raises blood counts further. Diabetes risk is discussed as another long term driver, with metformin mentioned as a protective option for some men. Kidney disease is discussed as a downstream consequence when blood pressure and metabolic risk remain uncontrolled. Stroke and heart attack are described as late outcomes that monitoring aims to prevent rather than react to. Closing guidance encourages consistent labs, early cardiometabolic action, and a long horizon mindset.